Patents by Inventor Eric T. Weimer

Eric T. Weimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR ENHANCED VIRTUAL CROSSMATCHING USING PHYSICAL-CROSSMATCH-OUTCOME-DATA-DERIVED MODEL
    Publication number: 20220392606
    Abstract: A method for virtual crossmatching using a physical-crossmatch-out-come-data-derived model includes receiving as inputs, human leukocyte antigen (HLA) antibody mean fluorescence intensity (MFI) data of a prospective tissue recipient and HLA typing data of a tissue donor. The method further includes generating, based on the inputs and a physical-crossmatch-outcome-data-derived model, a predicted virtual crossmatch outcome for the prospective tissue recipient. The method further includes using the predicted virtual crossmatch outcome to inform a transplant decision for the prospective tissue recipient.
    Type: Application
    Filed: November 13, 2020
    Publication date: December 8, 2022
    Inventors: Eric T. Weimer, Katherine A. Newhall
  • Flagellin Fusion Proteins and Use Thereof to Induce Immune Responses Against Pseudomonas aeruginosa
    Publication number: 20160193319
    Abstract: The invention provides compositions and fusion proteins comprising a flagellin adjuvant and a Pseudomonas aeruginosa antigen. The invention further provides pharmaceutical formulations and methods for inducing an immune response against P. aeruginosa (e.g., to prevent and/or treat P. aeruginosa infection).
    Type: Application
    Filed: January 6, 2016
    Publication date: July 7, 2016
    Inventors: Steven B. Mizel, Daniel J. Wozniak, Eric T. Weimer
  • Flagellin fusion proteins and use thereof to induce immune responses against
    Patent number: 9260509
    Abstract: The invention provides compositions and fusion proteins comprising a flagellin adjuvant and a Pseudomonas aeruginosa antigen. The invention further provides pharmaceutical formulations and methods for inducing an immune response against P. aeruginosa (e.g., to prevent and/or treat P. aeruginosa infection).
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: February 16, 2016
    Assignee: Wake Forest University Health Sciences
    Inventors: Steven B. Mizel, Daniel J. Wozniak, Eric T. Weimer
  • Flagellin Fusion Proteins and Use Thereof to Induce Immune Responses Against Pseudomonas Aeruginosa
    Publication number: 20150368303
    Abstract: The invention provides compositions and fusion proteins comprising a flagellin adjuvant and a Pseudomonas aeruginosa antigen. The invention further provides pharmaceutical formulations and methods for inducing an immune response against P. aeruginosa (e.g., to prevent and/or treat P. aeruginosa infection).
    Type: Application
    Filed: June 25, 2015
    Publication date: December 24, 2015
    Inventors: STEVEN B. MIZEL, DANIEL J. WOZNIAK, ERIC T. WEIMER
  • Flagellin fusion proteins and use thereof to induce immune responses against
    Patent number: 9096659
    Abstract: The invention provides compositions and fusion proteins comprising a flagellin adjuvant and a Pseudomonas aeruginosa antigen. The invention further provides pharmaceutical formulations and methods for inducing an immune response against P. aeruginosa (e.g., to prevent and/or treat P. aeruginosa infection).
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: August 4, 2015
    Assignee: Wake Forest University Health Sciences
    Inventors: Steven B. Mizel, Daniel J. Wozniak, Eric T. Weimer
  • FLAGELLIN FUSION PROTEINS AND USE THEREOF TO INDUCE IMMUNE RESPONSES AGAINST PSEUDOMONAS AERUGINOSA
    Publication number: 20120064106
    Abstract: The invention provides compositions and fusion proteins comprising a flagellin adjuvant and a Pseudomonas aeruginosa antigen. The invention further provides pharmaceutical formulations and methods for inducing an immune response against P. aeruginosa (e.g., to prevent and/or treat P. aeruginosa infection).
    Type: Application
    Filed: March 16, 2010
    Publication date: March 15, 2012
    Inventors: Steven B. Mizel, Daniel J. Wozniak, Eric T. Weimer